BELLEVUE GROUP AG – Alnylam Pharmaceuticals, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$191.50M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -9.58% | -101.42K shares | 37.16M | $200.16 | 956.76K |
| Q2 2022 | share | Decrease | -13.94% | -171.37K shares | -46.44M | $145.85 | 1.05M |
| Q1 2022 | share | Decrease | -7.91% | -105.57K shares | -25.63M | $163.29 | 1.22M |
| Q4 2021 | share | Decrease | -5.20% | -73.27K shares | -39.51M | $171.03 | 1.33M |
| Q3 2021 | share | Decrease | -9.08% | -140.67K shares | 3.32M | $188.81 | 1.40M |
| Q2 2021 | share | Decrease | -4.80% | -78.02K shares | 32.86M | $169.52 | 1.54M |
| Q1 2021 | share | Increase | +1.47% | 23.61K shares | 21.32M | $141.19 | 1.62M |
| Q4 2020 | share | Increase | +2.80% | 43.69K shares | -18.70M | $129.97 | 1.60M |
| Q3 2020 | share | Decrease | -3.12% | -50.26K shares | -11.35M | $145.6 | 1.55M |
| Q2 2020 | share | Decrease | -9.31% | -165.19K shares | 45.23M | $148.11 | 1.61M |
| Q1 2020 | share | Decrease | -4.80% | -89.51K shares | -21.53M | $108.85 | 1.77M |
| Q4 2019 | share | Decrease | -5.10% | -100.28K shares | 56.73M | $115.17 | 1.86M |
| Q3 2019 | share | Increase | +1.95% | 37.67K shares | 18.17M | $80.42 | 1.96M |
| Q2 2019 | share | Increase | +621.05% | 1.66M shares | 114.87M | $72.56 | 1.92M |
| Q1 2019 | share | Increase | +19.13% | 42.92K shares | 8.62M | $93.45 | 267.30K |
| Q4 2018 | share | Increase | +2.04% | 4.49K shares | -2.88M | $72.91 | 224.38K |
| Q3 2018 | share | Increase | +112.46% | 116.39K shares | 9.05M | $87.52 | 219.89K |
| Q2 2018 | share | Increase | +375.86% | 81.75K shares | 7.60M | $98.49 | 103.5K |
| Q1 2018 | share | Decrease | -1.58% | -350 shares | -218K | $119.1 | 21.75K |
| Q4 2017 | share | Decrease | -70.76% | -53.49K shares | -6.07M | $127.05 | 22.1K |
| Q3 2017 | share | Decrease | -39.54% | -49.43K shares | -1.09M | $117.49 | 75.59K |
| Q2 2017 | share | Decrease | -11.89% | -16.87K shares | 2.7M | $79.76 | 125.02K |
| Q1 2017 | share | Increase | +491.25% | 117.9K shares | 6.37M | $51.25 | 141.9K |
| Q4 2016 | share | 0.00% | 0 shares | -728K | $37.44 | 24K | |
| Q3 2016 | share | 0.00% | 0 shares | 295K | $67.78 | 24K | |
| Q2 2016 | share | 0.00% | 0 shares | -174K | $55.49 | 24K | |
| Q1 2016 | share | Increase | 0.00% | 24K shares | 1.50M | $62.77 | 24K |